ClearPoint Neuro, Inc. 8-K Filing Summary

This Form 8-K details the events of ClearPoint Neuro, Inc.'s annual stockholder meeting held on May 20, 2026. Key outcomes include the approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan, the ratification of Cherry Bekaert LLP as the independent registered public accounting firm for 2026, and the advisory approval of executive compensation. The meeting also saw the election of seven directors to serve until the 2027 annual meeting. Following the meeting, the Board of Directors appointed committee memberships, with Lynnette C. Fallon chairing the Audit Committee, B. Kristine Johnson chairing the Compensation Committee, and R. John Fletcher chairing the Corporate Governance and Nominating Committee. Mr. Fletcher was also confirmed as Chairman of the Board. The filing incorporates by reference the detailed description of the Incentive Compensation Plan from the company's definitive proxy statement and provides the full text of the plan as an exhibit.